Acceptability and utilisation of voluntary HIV testing and nevirapine to reduce mother-to-child transmission of HIV-1 integrated into routine clinical care by Urban, M & Chersich, M
ORIGINAL ARTICLES 
Acceptability and utilisation of voluntary HIV testing and 
nevirapine to reduce mother-to-child transmission of HIV-1 
integrated into routine clinical care 
M Urban, M Chersich 
Objectives. Use of nevirapine for prevention of mother-to-child 
transmission (PMTCT) of HlV-1 has been routine clinical care 
at Coronation Women and Children's Hospital since A.pr\1 
2000. We assessed the effect of regular. audit and targeted· 
interventions on the utilisation of the PMTCT programme. 
Methods .. Review of antenatal cards and hospital recQrcls of 
women discharged following delivery, in three time periods 
between October 2000 and February 2002. Following the 
. .initial audit an intervention was implemented to eliminat~ 
weaknesses. in our PMTCT service. Following the second 
audit the. hospital. became a pilot site for the Gauteng PMTCT 
programme. 
Results. In the initial audit 53.2% of women (159./2.99) were 
tested for HIV and received their resultst while 56% (14/25) 
of identified HIV-infected women, and 16% (4/25) of their 
infants, received nevirapine. By the third audit 74.3.% of 
The finding that a single dose of nevirapine administered to 
women during labour and to their infants after delivery 
reduced mother-to-child transmission of human 
immunodeficiency virus type 1 (HIV) by 47%' was a critical 
event. It made feasible the use of antiretrovirals for prevention 
of mother-to-child transmission (PMTCT) of HIV in poorly 
resourced settings.2 Nevirapine has been provided as part of 
routine care at Coronation Women and Children's Hospital 
(CWCH) since April2000. 
CWCH is affiliated to the University of the Witwatersrand. It 
provides primary, secondary and limited tertiary level obstetric 
and neonatal care facilities to a large urban and peri-urban 
population of western Johannesburg. Three district community 
clinics provide antenatal care in the area. None of these clinics 
provides intrapartum care, and only one had an established 
voluntary counselling and testing (VCT) system at the time of 
the first audit. 
Although simple, the nevirapine regimen poses several 
challeng~s. It requires a functional VCT programme for HIV 
1IfJ during antenatal care. The window of opportunity for 
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women (266/358) received their results, and 86% (43/50) of 
BIV+positive women and.74% (37/50) of newborns were 
documented to have received nevirapine. In all three audits 
over 90% of women initiating antenatal care at the hospital 
were tested for HIV, while women who initiated care at 
district community clinics were less likely to receive testing. 
Conclt~st'ons. Ongoing audit has been important for targeting 
obstacles to detection of HIV-infected women .and 
documented neyirapine uptake by women and infants. Rates 
of HlV te[?ting and nevirapine use have increased 
.significantly. Voluntary counselling and testing for HIV and 
use of nevirapine·are acceptable to pregnant women in our 
setting. Roll~out of the pilot programme to district community 
clinics is essential for further improvement. 
S Afr Med J 2004; 94: 362-366. 
intrapartum nevirapine is narrow- HIV-infected women 
should receive nevirapine at least 2 hours before delivery to 
ensure efficacy. Use of nevirapine before labour is problematic 
because of evidence that nevirapine-resistant mutations of HIV 
develop in approximately 20% of women3 and there are 
concerns that the rate will be higher if multiple doses are used. 
HIV-exposed infants should receive nevirapine within 48 - 72 
hours of delivery. The logistics of providing nevirapine are 
further complicated if, as occurs in our region, community 
clinics provide antenatal but not intrapartum care, and may or 
may not test for HIV. 
The objectives of the study were to describe deficiencies in 
the antenatal VCT service and in provision of nevirapine, and 
to assess changes following targeted interventions. 
Methods 
Audits were conducted in October 2000, April2001 and 
February 2002, and are referred to as audits 1, 2 and 3 
respectively. Each audit was conducted over a 2-week period. It 
comprised a retrospective review of hospital records and 
antenatal clinic cards collected for consecutively discharged 
patients from the postnatal wards at CWCH. Labour ward and 
postnatal ward staff were not informed of the audit dates. 
Information was collected regarding: (i) attendance at and site 
of antenatal care; (ii) whether an HIV test was done; (iii) 
whether women received their HIV test result; (iv) whether a 
rapid plasma reagin (RPR) test for syphilis was done (for 
comparison purposes); and (v) whether nevirapine use was 
documented for mother and infant. Antenatal cards and 
hospital records of those not tested were assessed for missed 
opportunities for VCT at CWCH. 
Women initiating antenatal care at CWCH receive VCT, and 
if they consent, are tested for HIV at the first visit. At the time 
audit 1 was conducted a laboratory enzyme-linked 
immunosorbent assay (ELISA) test was used. HIV-infected 
women were identified at the second visit and referred to the 
antenatal HIV clinic. One of the community clinics had a VCT 
system, but the other clinics tested only sporadically. In the 
interests of confidentiality results were documented cryptically 
on the patient-held antenatal card. Each clinic had its own 
method of documentation. HIV-infected women who presented 
to the hospital in labour were identified by the nursing staff 
and given nevirapine. In the postnatal wards, infants were 
detected and treated in a similar manner. 
Problems with the operational aspects identified in the initial 
audit (Table I) were addressed initially by means of an 
intervention to increase staff awareness. This included 
discussions with relevant staff, and a poster campaign in the 
hospital to target the problems identified. The audit was 
repeated in April 2001,2 months after the intervention. 
With the implementation of the national PMTCT pilot project 
(described by McCoy et al.') in October 2001, CWCH became a 
provincial pilot site. Audit 3 was conducted in February 2002. 
While the pilot project provided additional resources to the 
hospital, the community clinics were not included. 
Table I. Process of audit and intervention 
Statistical analysis was conducted using Epi-Info 2000. Audit 
data were compared using a chi-square or Fisher's exact test as 
appropriate. Audit 1 was used as a control group for audit 2, 
and audit 2 for audit 3. 
The study was approved by the University of the 
Witwatersrand Committee for Research on Human Subjects, 
protocol number MOl-04-23. 
Results 
A total of 965 records were assessed across the three audits. 
Audit data for the whole group, and for those initiating 
antenatal care at CWCH, are presented in Tables II and Ill 
respectively. 
The system for syphilis testing was efficient in all audits, 
whether antenatal care was initiated at CWCH or elsewhere. A 
total of 900/965 records (93.3%) had a rapid plasma reagin 
(RPR) result documented. 
The rate of HIV testing differed markedly between women 
who initiated antenatal care at CWCH and those who did not. 
In total424/965 women (43.9%) initiated antenatal care at 
CWCH, forming a similar proportion in each audit. The rates 
of testing for HIV among these subjects were above 90% for all 
the audits, with 401/424 (94.5%) receiving HIV testing. 
Of the 965 women, 541 (56.0%) did not start antenatal care at 
CWCH. Most of these subjects initiated antenatal care at the 
community clinics, while 71 patients (7.4% of all subjects) 
received no antenatal care. The rate of HIV testing among these 
women was poor in audit 1, with only 37.2% (64/172) tested. 
This improved to 64.1% (109 /170) and 74.9% (149/199) in 
Changes introduced by PMTCT 
Pro\:lleins at initial audit Probable reason/s for problem Interventions following aud~t 1 ·pilot project · · 
Failure to offer 
VCT at community clinics 
Failure to test at hospital 
antenatal clinic visit 
Lack of VCT knowledge, 
skills and resources 
Lack of staff awareness 
Clinic staff informed a\:Jout 
availa\:Jility of VCT training 
and encouraged to implement VCT · 
Staff education 
Failure to obtain HIV results Lack of staff awareness Staff education 
No maternal dose of Lack of staff awareness Staff education 
nevirapine recorded OR Women presenting in 
advanced labour OR Difficulty 
. interpreting encoc:J.ed ~;esult!5 
OR Poor documentation . . 
No il.lfanf dose ofiH~virapine 
recorded 
VCT ~ voluntary counselling and testing. 
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Lack of staffawareness OR Staff education 
Difficulty interpreting encoded 
results OR Poor documentation 
Salaried lay counsellors. 
'Rapid' on-site tests 
Women received nevirapine to take 
.home for self-administration 
Lay counsellors 
monitor infant dosing 
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Table n. HIV testing and nevi:rapine use for all patients 
Audit 1 Audit 2 p-value* 
October 2000 March2001 (audit2v. 
(N.= ~99) (N"' 308) audit1) 
BIV tested (No .. (%)) 181 (60.5) 242 (78.6) < 0.001 
HIV results obtained 159 (87.8) 21::) (88;0) 0.95 
antenatally (as % of 
the tested) 
ELISA-positive 27 (14.9) 58 (24:0) 
(as % of tested) 
Positive results obtained 25 (93) 51 (88) 0.79 
antenatally (% of positives) 
Mother received nevirapine 14 (56) 39 (76) 0.07 
(as % ofantenataLpositives) 
Nevirapine 2-48 hours Not checked 26 (67) 
before delivery (as % of 
those receiving nevirapine) 
Baby received nevirapine 4 (16) 23 (45) 0.01 
(as % of antenatal positives) 
* Chi~~quare, or Eishe~' s exact test. 
Table in. HIV testing and nevirapine use for. subjectS l!litiating anteMta1 care at CWCH 
HIV tested (No. (%)) 
HlVresults obtained 
antenatally (as % of· 
the tested) 
ELISA-positive (as % 
of the tested) 
Audit 1 Audit 2 · p-value* 
October 20QO March 2001 (audit 2 v. 
(N = 127j (N"' 138) audit 1) 
117 (92.1) 133 (96:4) 0.13 
101 (86.3) 130 (97.7) <0.001 
10 (8.5) 23 (17.3) 
Positive results obtained 8 (80) 22 (96) 0.21 
antenatally (% of 
positives) 
Mother. received 6 (75) 21 (95) 0;17 
nevirapine (as % of 
antenatal positives) 
Nevirapine 2 • 48 hours Not checked 14 (67) 
before delivery (a~ % of 
those rec:elving nevirapine) 
Baby received nevirapine 1 (12.5) 7 (30) 0.39 
(as % of antenatal positives) 
*C~i~squ~re, or fisher's exact test. 
Audit3 
February 2002 




































audits 2 and 3 respectively. As there may have been missed 
opportunities for testing at CWCH before the onset of labour, 
the frequency of missed opportunities in untested women was 
assessed in audits 1 and 2. There were 51 missed opportunities 
in audit 1 compared with 24 in audit 2. 
The rate at which women received nevirapine increased 
significantly between audits 1 and 3 (p = 0.004, chi-square). 
The only women who received nevirapine to take home for 
self-administration were those initiating antenatal care at 
CWCH in audit 3. None of these women took their nevirapine 
more than 48 hours before delivery. 
May 2004, Vol. 94, No. 5 SAMJ 
Discussion 
The study demonstrates significant improvements over time in 
the rates of testing for HIV. Audit 1 showed that the CWCH 
antenatal clinic provided an effective VCT and HIV testing 
programme for those initiating antenatal care at the hospital, 
and demonstrates that HIV testing is well accepted by women 
attending antenatal care. Among women not initiating 
antenatal care at CWCH the rate of HIV testing was low 
because several community clinics did not have a well-
established VCT system. Testing rates improved over time, but 
remained suboptimal. The fact that RPR testing was provided 
efficiently suggests that these clinics give competent antenatal 
care, and that with appropriate support they should be able to 
implement VCT for HIV. Although there was a reduction in 
missed opportunities for HIV testing at CWCH, in many cases 
there were no opportunities for HIV testing at the hospital. We 
concur with the recommendation of McCoy et al.' that the 
PMTCT programme should be developed and integrated into 
other related programmes at subdistrict level. 
The proportion of HIV tests for which results were obtained 
did not improve between the audits, except among women 
who initiated antenatal care at CWCH between audits 1 and 2. 
For these patients virtually all results were obtained once staff 
awareness improved, because undocumented results are 
readily accessible by computer. Thus the introduction of a 
rapid HIV test yielded no further improvement, contrary to the 
findings of a previous study' demonstrating increased uptake 
of testing with a rapid test compared with a laboratory ELISA 
test. The use of a rapid test would more likely have been useful 
in the community clinics, where there were persistent problems 
with obtaining HIV results. 
The maternal dose of nevirapine should be taken between 2 
and 48 hours before delivery. Nearly one-third of women who 
received nevirapine did not take it in this time period (i.e. 
timeously). One might expect that women would tend to take 
nevirapine too late if it is only dispensed by labour ward staff, 
and too early if they self-administer it. However, in only one 
case was the nevirapine taken too early and this was 
administered by hospital staff. In the small group of subjects 
who received nevirapine for self-administration there was no 
significant improvement in the rate at which these women took 
their nevirapine, or in the rate that they took it timeously. It is 
likely that self-administration of nevirapine would be more 
important for women who live further away from the hospital, 
particularly those attending community clinics. Reasons for 
failure to self-administer nevirapine at the correct time require 
further elucidation. Our impression is that some women find it 
difficult to decide when to take their nevirapine, or may 
misplace the tablet. It is therefore important that women be 
counselled on the correct use of nevirapine and that the labour 
ward staff confirm that nevirapine has been taken. 
May 2004, Vol. 94, No. 5 SAMJ 
The emphasis on maternal diagnosis and prophylaxis may 
result in an underemphasis on giving nevirapine to the infant. 
However, this is an integral part of the regimen. In addition, 
post-exposure prophylaxis with neonatal nevirapine may be 
important if women do not receive nevirapine or do not receive 
it timeously (G Gray et al.- paper presented at the 14th 
International AIDS Conference, Barcelona, 2002 (abstract No. 
LbOR13)). The neonatal dose of nevirapine was infrequently 
documented at the initial audit. This improved, but by the 
third audit neonatal nevirapine was still not documented in 
one-quarter of cases. The neonatal dose is given in the 
postnatal wards, and requires that the antenatal card and 
delivery notes be rechecked and nevirapine given accordingly. 
The confidential nature of information regarding HIV status 
unintentionally increases the risk of missed opportunities for 
nevirapine use. Some women are reluctant to notify staff of 
their status. This is unlikely to change until stigma related to 
HIV-positive status reduces. In addition, it has proved difficult 
to develop a uniform but confidential system of documentation 
for HIV results. 
The fact that almost half of the identified HIV-infected 
women in audit 1 were not documented to have received 
nevirapine may reflect poor documentation. The study was 
limited by the fact that it relied on written documentation in 
the antenatal cards and hospital records, and it was not 
possible to differentiate with certainty between medication not 
given and medication not documented. While we attempted to 
improve documentation, we feel that for audit purposes it is 
appropriate to assume that 'not documented means not done'. 
Another limitation was the retrospective collection of data, 
resulting in an inability to collect information on women who 
received antenatal care in our service but delivered elsewhere. 
It has been noted that public health interventions in 
developing countries, such as the Expanded Programme for 
Immunisation, have taken some time to achieve adequate 
coverage.' In view of our use of historical control groups, it is 
not possible to be certain that the improvements documented 
were due to the interventions applied rather than related to the 
passage of time. However, it seems very likely that ongoing 
quality control through audit and intervention has been 
important in the improvement our PMTCT programme. It is 
apparent from our results that the incremental effect of drop-
offs at several stages in the process of HIV testing, obtaining 
results and providing nevirapine on the overall efficiency of 
the PMTCT programme can be very large. Attention to each 
detail is therefore essential. 
Conclusion 
The overall efficiency of our PMTCT service improved from 
audit to audit. Testing for HIV and use of nevirapine were well 
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accepted. The main shortcomings with HIV testing were 
among women who initiated antenatal care outside the 
hospital. Roll-out of the PMTCT pilot project to the community 
clinics is essential. In addition, significant challenges remain in 
the provision of nevirapine to newborns, and in the timing of 
the maternal dose. Similar to many other public health 
interventions, the PMTCT programme requires ongoing quality 
control to ensure effectiveness. 
Our thanks to the hospital counselling staff, health workers, and 
Professors K Bolton and S Levin. 
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,1\.sthJila isthemOst··c6rnmonoccupati9Dal,.luQgdis~a~e in industrialised countries, occupational. exposures being responsible 
for.S .• 20% of all ad !,lit asthma cases; Severaii=OIT\ml:lnity-based .. studies have recently shown an increased risk for asthma in 
tl~an~rs, an· ticcup~tion not tniditio~ally .• assoclated,vVlth.t!)l~·.··,usease; 
To. assess .the ·risk·of.asthma·.in womeniemployed.'in4t>me~tkdea11l.ng,~ gro~p ?tr~searcher-s i~cSpaitlcon~u~tecJ·a cro$S• 
sectional study in 4. 521. women. ag~d 30 .. (>5 years.lnformati<:>;no(l resP<i\at()ry symptoms and deanin~ vvqrk histot~:was 
obtained using a posted questionnaire, with telephonicfollow•up.Asthma wa.s defined as r:eportei:l syrnptorns within the last 
year, &r.current. use. of&ugs to t~ea~ astbfl1a• Th~q~estionnaire requ~stei:l answers .. t6 .. questlons about wheezing. 
brea~hlessf)ess, previous asthrna1nocturn~l dyspnoea! drug use for asJ:hma, c()ugh, [lhlegrn,runny .nose or sneezing without a 
cold, and jol;>-related r~spiratqryprqblems;Work•related. questions .enquired about. the .location of the work (domestic or 
.·.· Mn,.domestic), titl)ing a(I~:Ltype qf work. · 
pft~e ~otal enrqlment,S93 Of 4~2l Wqnjenwere ef11ployed.as domestic deaners.~sthmawas .. more prevalent in this group 
tha.n •• in.;vomef1. who .• hadneverwork~d .• ill ~leaning,F0r:rner dorne~tic workwasrtjport7~ by·l ...• 170· worn.en •. and was strongly 
assogia~ed with .asthma .. C~rrent and fo~m7rn.pn-dorn~stir.; .cl~~ningVfa,s not significantly associated .with .asthma, Twenty~five 
per. cent of the. asthma cases • in the study pop.ulatiori were a!ltribut~l;>le to domestic cleaning work: 
·.··This study. siJgg~sts ~hat not only .p.rof~ssional dorllE)stid ~lear\¢rs bt)t p.e:opl~ 4ndel'~!<ing.ci~aning.ta$ks at home ar~ at risk.· of 
asthm~. . . . .. . . . . . ·. . . .. . . .··· . · ..... · .. < · .. ··.· · ... ··.· .. .. . . .·· ·... • . . . . .•. . ... · ..• ·. .. • . .. . ... 
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